The seasoned approach
SNF psychiatric work in 2026. The discipline of effective care in the skilled nursing facility setting — the patient population, the constraints, the work that produces good outcomes despite the limitations.
Layer 1 — First — engage the actual patient population
Most SNF psychiatric patients have advanced dementia with BPSD, severe medical comorbidity, frailty, substantial polypharmacy. Some have primary psychiatric conditions (severe depression, bipolar, schizophrenia) aging into care. The work matches the population — not outpatient psychiatry transplanted to SNF setting.
Layer 2 — Comprehensive medication audit at every visit
SNF patients accumulate medications across years and multiple providers. Audit ruthlessly. Discontinue what is not actively needed. Particular attention to: psychotropics no longer indicated, anticholinergic burden, sedating combinations, antipsychotics started for acute scenarios and continued indefinitely. The deprescribing work is some of the highest-leverage SNF psychiatric care.
Layer 3 — BPSD management with discipline
Non-pharmacological first (Stage 25.2). Address reversible contributors — UTI, pain, constipation, medication effects, environmental factors. Use evidence-based agents (citalopram, brexpiprazole) when pharmacological treatment needed. Avoid the casual antipsychotic prescribing pattern that drives much of the regulatory concern about SNF psychiatric care.
Layer 4 — Depression recognition and treatment
Depression in advanced dementia is frequently missed (Stage 25.4). Use behavioral observation and informant report. Treat appropriately — meaningful improvement in function and quality of life is achievable.
Layer 5 — Family engagement
Family dynamics shape much of SNF psychiatric care — what they want, what they can do, what they understand about the trajectory. Engage families thoughtfully. Advance care planning conversations are part of standard care. Documentation of family preferences shapes future decisions.
Layer 6 — Regulatory and quality framework
CMS regulations about antipsychotic use, restraint use, polypharmacy create real constraints that shape care. Quality measures matter. The constraints reflect real concerns about historical practice; engage them constructively rather than work around them. Quality SNF psychiatric care satisfies the regulations while serving patient needs.
Special situations
- SNF resident on multiple psychotropics for years: Systematic medication audit. Identify what started when and why. Identify what is still indicated. Plan systematic taper of unnecessary medications — slow, respectful, monitored. Most SNF patients on substantial polypharmacy can be substantially simplified.
- New severe behavioral disturbance: Medical workup first — UTI, pneumonia, pain, constipation, medication. Address reversible contributors. Non-pharmacological interventions. If pharmacological needed, evidence-based choice (citalopram, brexpiprazole) with informed consent including the antipsychotic mortality warning if applicable.
- Family wanting aggressive intervention vs. comfort care: Engage the conversation seriously. What is the patient's prior wishes; what is current trajectory; what does aggressive intervention mean in practical terms; what would comfort care look like. Coordinate with primary care and medical specialists. Document the discussion and decisions thoroughly.
- Patient with primary psychiatric illness aging in: Continue evidence-based treatment for the primary condition with attention to age-related considerations. The bipolar patient at 78 in SNF still needs mood stabilization; the schizophrenia patient at 75 may still need antipsychotic. The challenge is integrating with frailty, medical illness, and SNF context.
Generally avoid
- Generic sedation as default response to behavioral symptoms — non-pharmacological first; specific agents for specific symptoms; not casual antipsychotic prescribing.
- Accumulating medications without periodic audit — the SNF patient who has been on the same regimen for years without review is likely on inappropriate medications.
- Ignoring depression as "just dementia" — depression in advanced dementia is treatable; ignoring it perpetuates substantial unnecessary suffering.
- Treating SNF psychiatry as substandard outpatient psychiatry — it is its own discipline with specific patient population, constraints, and practices.
The chief-resident note: SNF psychiatric work is some of the most important and most underrated care in medicine. The patient population is profoundly vulnerable; the small clinical decisions matter enormously; the deprescribing work alone produces measurable quality of life and longevity benefit. Build the practice for this work specifically — the patient population, the constraints, the regulatory environment, the family dynamics, and the discipline of evidence-based care in this setting are all distinct from outpatient psychiatry. Engage seriously.
The skilled nursing facility reality represents one of the most important and underappreciated areas of psychiatric care. The patient population — advanced dementia with substantial BPSD, severe medical comorbidity, frailty, polypharmacy, sometimes primary psychiatric illness aging into care — is profoundly vulnerable. The constraints — regulatory environment, staffing realities, family dynamics, payer considerations — are real. The clinical work that produces good outcomes despite these constraints is its own discipline.
The patient population reality. Most SNF psychiatric consultation involves dementia patients with BPSD — agitation, psychosis, depression, sleep disturbance, refusal of care. Patients with severe primary psychiatric illness (chronic schizophrenia, bipolar disorder, severe recurrent depression) aging into SNF care add complexity. Frailty, medical comorbidity, and polypharmacy are universal. The work is integrated medical-psychiatric care, not pure psychiatry.
The medication audit as central work. SNF patients accumulate medications across years from multiple providers across multiple settings. Periodic comprehensive medication audit — confirming what each medication is for, whether still needed, what could be discontinued or reduced — is some of the highest-leverage clinical work available. Particular attention to: psychotropics started for acute scenarios continuing indefinitely, anticholinergic burden, sedating combinations, medications without current indication. Systematic deprescribing produces measurable cognitive and functional improvement.
The BPSD management discipline. Non-pharmacological first (Stage 25.2). Address reversible contributors — UTI is the classic missed cause of acute behavioral change. Pain assessment thoroughly (frequently missed). Constipation. Environmental factors. Medications. When pharmacological treatment is needed, evidence-based agents with specific indications — citalopram for agitation, brexpiprazole specifically approved for AD agitation, trazodone for sleep, SSRI for depression. Avoid the casual antipsychotic prescribing that has driven much of the regulatory and quality concern about SNF psychiatric care.
The regulatory and quality framework. CMS regulations about antipsychotic use, restraints, polypharmacy reflect historical concerns about overuse. Quality measures matter. Engage constructively rather than work around. Quality SNF psychiatric care satisfies the regulatory framework while serving patient needs — the documentation of clinical reasoning, family discussions, monitoring, and discontinuation efforts is part of clinical practice.
The family engagement. Family dynamics shape much of SNF care. What family wants, what they can do, what they understand about trajectory — these inform treatment decisions. Advance care planning conversations are standard care, not optional. Documentation of preferences, surrogate decision-making, treatment intensity discussions matter. The integrated care includes the family as much as the patient. The discipline is to engage SNF psychiatric work as its own clinical discipline — match care to the population, audit medications systematically, manage BPSD evidence-based, engage families meaningfully, and integrate with the broader interdisciplinary care that good SNF practice requires.
The anchor
SNF psychiatric work serves vulnerable population (advanced dementia with BPSD, frailty, polypharmacy) within real constraints (regulatory, staffing, family). Discipline includes: comprehensive medication audit, evidence-based BPSD management, depression recognition, family engagement, regulatory compliance. Its own clinical discipline.